| Title |
Mortality Associated with Attention-Deficit Hyperactivity Disorder (ADHD) Drug Treatment
|
|---|---|
| Published in |
Drug Safety, November 2012
|
| DOI | 10.2165/11317630-000000000-00000 |
| Pubmed ID | |
| Authors |
Suzanne McCarthy, Noel Cranswick, Laura Potts, Eric Taylor, Ian C. K. Wong |
| Abstract |
Following reports of sudden death in patients taking medication to treat attention-deficit hyperactivity disorder (ADHD), this study aimed to identify cases of death in patients prescribed stimulants and atomoxetine and to determine any association between these and sudden death. |
X Demographics
The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 2 | 22% |
| Bosnia and Herzegovina | 1 | 11% |
| Unknown | 6 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 6 | 67% |
| Practitioners (doctors, other healthcare professionals) | 2 | 22% |
| Scientists | 1 | 11% |
Mendeley readers
The data shown below were compiled from readership statistics for 118 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 2% |
| United Kingdom | 1 | <1% |
| Spain | 1 | <1% |
| Australia | 1 | <1% |
| Unknown | 113 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 25 | 21% |
| Student > Master | 20 | 17% |
| Student > Ph. D. Student | 12 | 10% |
| Student > Bachelor | 11 | 9% |
| Student > Doctoral Student | 9 | 8% |
| Other | 21 | 18% |
| Unknown | 20 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 39 | 33% |
| Psychology | 25 | 21% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 4% |
| Social Sciences | 3 | 3% |
| Economics, Econometrics and Finance | 3 | 3% |
| Other | 14 | 12% |
| Unknown | 29 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 April 2024.
All research outputs
#2,680,409
of 25,753,578 outputs
Outputs from Drug Safety
#275
of 1,872 outputs
Outputs of similar age
#24,290
of 287,203 outputs
Outputs of similar age from Drug Safety
#92
of 815 outputs
Altmetric has tracked 25,753,578 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,872 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.9. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 287,203 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 815 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.